Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical Industries has announced that the FDA has granted approval for the abbreviated new drug application to market benzonatate capsules.
Subscribe to our email newsletter
Benzonatate USP capsules are therapeutically equivalent to Forest Lab’s Tessalon, and are available in two strengths: capsules containing 100mg and 200mg benzonatate USP.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections. This product will reach market shortly.